HIBADH (3-hydroxyisobutyrate dehydrogenase) has been previously implicated in insulin resistance and risk of incident type 2 diabetes and gestational diabetes mellitus (Nilsen et al., 2020). Here, HIBADH is linked to Insulin resistance.